{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:06:55Z","timestamp":1791576415900,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00115-024-01721-6","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:03:15Z","timestamp":1722452595000},"page":"824-829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kratom \u2013 vom nat\u00fcrlichen Heilmittel zur Suchtdroge und zur\u00fcck","Kratom\u2014From natural remedy to addictive drug and back"],"prefix":"10.1007","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5325-9900","authenticated-orcid":false,"given":"Christian P.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"issue":"5","key":"1721_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/15563650.2020.1812627","volume":"59","author":"MF Abdullah","year":"2021","unstructured":"Abdullah\u00a0MF, Tan\u00a0KL, Narayanan\u00a0S et\u00a0al (2021) Is kratom (Mitragyna speciosa Korth.) use associated with ECG abnormalities? Electrocardiogram comparisons between regular kratom users and controls. Clin Toxicol 59(5):400\u2013408","journal-title":"Clin Toxicol"},{"issue":"1","key":"1721_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jep.2012.03.009","volume":"141","author":"K Ahmad","year":"2012","unstructured":"Ahmad\u00a0K, Aziz\u00a0Z (2012) Mitragyna speciosa use in the northern states of Malaysia: a\u00a0cross-sectional study. J\u00a0Ethnopharmacol 141(1):446\u2013450","journal-title":"J Ethnopharmacol"},{"issue":"14","key":"1721_CR3","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1080\/10826080701205869","volume":"42","author":"S Assanangkornchai","year":"2007","unstructured":"Assanangkornchai\u00a0S, Muekthong\u00a0A, Sam-Angsri\u00a0N, Pattanasattayawong\u00a0U (2007) The Use of Mitragynine speciosa (\u201cKrathom\u201d), an addictive plant, in Thailand. Subst Use Misuse 42(14):2145\u20132157","journal-title":"Subst Use Misuse"},{"issue":"2","key":"1721_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/15563650701241795","volume":"46","author":"KM Babu","year":"2008","unstructured":"Babu\u00a0KM, McCurdy\u00a0CR, Boyer\u00a0EW (2008) Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol 46(2):146\u2013152","journal-title":"Clin Toxicol"},{"issue":"3","key":"1721_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/ADM.0000000000000570","volume":"14","author":"R Bath","year":"2020","unstructured":"Bath\u00a0R, Bucholz\u00a0T, Buros\u00a0AF et\u00a0al (2020) Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey. J\u00a0Addict Med 14(3):244\u2013252","journal-title":"J Addict Med"},{"key":"1721_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","volume":"103","author":"EW Boyer","year":"2008","unstructured":"Boyer\u00a0EW, Babu\u00a0KM, Adkins\u00a0JE et\u00a0al (2008) Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa Korth.). Addiction 103:1048\u20131050","journal-title":"Addiction"},{"key":"1721_CR7","first-page":"1480","volume-title":"A Dictionary of the Economic Products of the Malay Peninsula","author":"IH Burkill","year":"1935","unstructured":"Burkill\u00a0IH (1935) A Dictionary of the Economic Products of the Malay Peninsula Bd. II, S\u00a01480\u20131483"},{"key":"1721_CR8","doi-asserted-by":"publisher","first-page":"968786","DOI":"10.1155\/2015\/968786","volume":"2015","author":"E Cinosi","year":"2015","unstructured":"Cinosi\u00a0E, Martinotti\u00a0G, Simonato\u00a0P et\u00a0al (2015) Following \u201cthe Roots\u201d of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a\u00a0Traditional Use to Increase Work and Productivity in Southeast Asia to a\u00a0Recreational Psychoactive Drug in Western Countries. Biomed Res Int 2015:968786","journal-title":"Biomed Res Int"},{"key":"1721_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugalcdep.2019.05.005","volume":"202","author":"MA Coe","year":"2019","unstructured":"Coe\u00a0MA, Pillitteri\u00a0JL, Sembower\u00a0MA et\u00a0al (2019) Kratom as a\u00a0substitute for opioids: Results from an online survey. Drug Alcohol Depend 202:24\u201332","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"1721_CR10","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1021\/acs.jnatprod.0c00257","volume":"83","author":"L Flores-Bocanegra","year":"2020","unstructured":"Flores-Bocanegra\u00a0L, Raja\u00a0HA, Graf\u00a0TN et\u00a0al (2020) The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids. J\u00a0Nat Prod 83(7):2165\u20132177","journal-title":"J Nat Prod"},{"key":"1721_CR11","doi-asserted-by":"publisher","first-page":"107849","DOI":"10.1016\/j.drugalcdep.2020.107849","volume":"208","author":"A Garcia-Romeu","year":"2020","unstructured":"Garcia-Romeu\u00a0A, Cox\u00a0DJ, Smith\u00a0KE et\u00a0al (2020) Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend 208:107849","journal-title":"Drug Alcohol Depend"},{"key":"1721_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","volume":"176","author":"O Grundmann","year":"2017","unstructured":"Grundmann\u00a0O (2017) Patterns of Kratom use and health impact in the US-Results from an online survey. Drug Alcohol Depend 176:63\u201370","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1721_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/00952990.2022.2041026","volume":"48","author":"O Grundmann","year":"2022","unstructured":"Grundmann\u00a0O, Veltri\u00a0CA, Morcos\u00a0D et\u00a0al (2022) Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a\u00a0cross-sectional investigation. Am J Drug Alcohol Abuse 48(4):433\u2013444","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1721_CR14","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000632","author":"O Grundmann","year":"2023","unstructured":"Grundmann\u00a0O, Veltri\u00a0CA, Morcos\u00a0S et\u00a0al (2023) Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a\u00a0cross-sectional survey. Exp Clin Psychopharmacol. https:\/\/doi.org\/10.1037\/pha0000632","journal-title":"Exp Clin Psychopharmacol"},{"key":"1721_CR15","doi-asserted-by":"publisher","first-page":"101442","DOI":"10.1016\/j.disamonth.2022.101442","volume":"69","author":"O Grundmann","year":"2023","unstructured":"Grundmann\u00a0O, Hendrickson\u00a0RG, Greenberg\u00a0MI (2023) Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits. Dis Mon 69:101442","journal-title":"Dis Mon"},{"issue":"5","key":"1721_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/jcph.2001","volume":"62","author":"C Hartley","year":"2022","unstructured":"Hartley\u00a0C, Bulloch\u00a0M, Penzak\u00a0SR (2022) Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa). J\u00a0Clin Pharmacol 62(5):577\u2013593","journal-title":"J Clin Pharmacol"},{"key":"1721_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fpsyt.2020.00411","volume":"11","author":"R Hassan","year":"2020","unstructured":"Hassan\u00a0R, See\u00a0CP, Sreenivasan\u00a0S et\u00a0al (2020) Mitragynine attenuates morphine withdrawal effects in rats\u2014a\u00a0comparison with methadone and buprenorphine. Front Psychiatry 11:411","journal-title":"Front Psychiatry"},{"issue":"2","key":"1721_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","volume":"37","author":"Z Hassan","year":"2013","unstructured":"Hassan\u00a0Z, Muzaimi\u00a0M, Navaratnam\u00a0V et\u00a0al (2013) From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev 37(2):138\u2013151","journal-title":"Neurosci Biobehav Rev"},{"issue":"Suppl.1","key":"1721_CR19","first-page":"P01","volume":"26","author":"U Havemann-Reinecke","year":"2011","unstructured":"Havemann-Reinecke\u00a0U (2011) Kratom and alcohol dependence: Clinical symptoms, withdrawal treatment and pharmacological mechanisms\u2014a\u00a0case report. Eur Psychiatry 26(Suppl.1):P1\u2013P50","journal-title":"Eur Psychiatry"},{"key":"1721_CR20","doi-asserted-by":"publisher","first-page":"105851","DOI":"10.1016\/j.ypmed.2019.105851","volume":"128","author":"JE Henningfield","year":"2019","unstructured":"Henningfield\u00a0JE, Grundmann\u00a0O, Babin\u00a0JK et\u00a0al (2019) Risk of death associated with kratom use compared to opioids. Prev Med 128:105851","journal-title":"Prev Med"},{"issue":"5","key":"1721_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/adb.12639","volume":"24","author":"SE Hemby","year":"2019","unstructured":"Hemby\u00a0SE, McIntosh\u00a0S, Leon\u00a0F et\u00a0al (2019) Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7\u2011hydroxymitragynine. Addict Biol 24(5):874\u2013885","journal-title":"Addict Biol"},{"key":"1721_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/10826080903443628","volume":"45","author":"J Hillebrand","year":"2010","unstructured":"Hillebrand\u00a0J, Olszewski\u00a0D, Sedefov\u00a0R (2010) Legal highs on the Internet. Subst Use Misuse 45:330\u2013340","journal-title":"Subst Use Misuse"},{"key":"1721_CR23","first-page":"1095","volume":"54","author":"EM Holmes","year":"1895","unstructured":"Holmes\u00a0EM (1895) Some medicinal products from the Straits settlements. Pharm\u00a0J 54:1095\u20131096","journal-title":"Pharm J"},{"key":"1721_CR24","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/adb.12385","volume":"22","author":"NI Ismail","year":"2017","unstructured":"Ismail\u00a0NI, Jayabalan\u00a0N, Mansor\u00a0SM et\u00a0al (2017) Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice. Addict Biol 22:967\u2013976","journal-title":"Addict Biol"},{"key":"1721_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0378-8741(88)90121-3","volume":"23","author":"KL Jansen","year":"1988","unstructured":"Jansen\u00a0KL, Prast\u00a0C (1988) Ethnopharmacology of kratom and the Mitragyna alkaloids. J\u00a0Ethnopharmacol 23:115\u2013119","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"1721_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/10550887.2021.1981122","volume":"40","author":"RK Jasim","year":"2022","unstructured":"Jasim\u00a0RK, Hassan\u00a0Z, Singh\u00a0D et\u00a0al (2022) Characterization of urinary protein profile in regular kratom (Mitragyna speciosa korth.) users in Malaysia. J\u00a0Addict Dis 40(2):235\u2013246","journal-title":"J Addict Dis"},{"issue":"2","key":"1721_CR27","first-page":"283","volume":"93","author":"LE Johnson","year":"2020","unstructured":"Johnson\u00a0LE, Balyan\u00a0L, Magdalany\u00a0A et\u00a0al (2020) The Potential for Kratom as an Antidepressant and Antipsychotic. Yale J Biol Med 93(2):283\u2013289","journal-title":"Yale J Biol Med"},{"key":"1721_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11419-009-0070-5","volume":"27","author":"R Kikura-Hanajiri","year":"2009","unstructured":"Kikura-Hanajiri\u00a0R, Kawamura\u00a0M, Murayama\u00a0T et\u00a0al (2009) Simultaneous analysis of mitragynine, 7\u2011hydroxymitragynine, and other alkaloids in the psychotropic plant \u201ckratom\u201d (Mitragyna speciosa) by LC-ESI-MS. Forensic Toxicol 27:67\u201374","journal-title":"Forensic Toxicol"},{"issue":"21","key":"1721_CR29","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1021\/jacs.6b00360","volume":"138","author":"AC Kruegel","year":"2016","unstructured":"Kruegel\u00a0AC, Gassaway\u00a0MM, Kapoor\u00a0A et\u00a0al (2016) Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators. J\u00a0Am Chem Soc 138(21):6754\u20136764","journal-title":"J Am Chem Soc"},{"key":"1721_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ajp.2019.07.008","volume":"43","author":"MF Leong Bin Abdullah","year":"2019","unstructured":"Leong Bin Abdullah\u00a0MF, Singh\u00a0D, Swogger\u00a0MT et\u00a0al (2019) The prevalence of psychotic symptoms in kratom (Mitragyna speciosa Korth.) Users in Malaysia. Asian J Psychiatry 43:197\u2013201","journal-title":"Asian J Psychiatry"},{"issue":"4","key":"1721_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/08897077.2021.1876809","volume":"42","author":"MF Leong Bin Abdullah","year":"2021","unstructured":"Leong Bin Abdullah\u00a0MF, Yuvashnee\u00a0N, Singh\u00a0D (2021) Effect of regular kratom (Mitragyna speciosa Korth.) use on quality of life of people who use kratom. Subst Abuse 42(4):444\u2013449","journal-title":"Subst Abuse"},{"key":"1721_CR32","doi-asserted-by":"publisher","first-page":"726003","DOI":"10.3389\/fphar.2021.726003","volume":"12","author":"MF Leong Bin Abdullah","year":"2021","unstructured":"Leong Bin Abdullah\u00a0MF, Singh\u00a0D (2021b) The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A\u00a0Comprehensive Review. Front Pharmacol 12:726003","journal-title":"Front Pharmacol"},{"issue":"1","key":"1721_CR33","first-page":"145","volume":"198","author":"E Macko","year":"1972","unstructured":"Macko\u00a0E, Weisbach\u00a0JA, Douglas\u00a0B (1972) Some observations on the pharmacoloy of mitragynine. Arch Int Pharmacodyn Ther 198(1):145\u2013151","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1721_CR34","doi-asserted-by":"publisher","first-page":"114251","DOI":"10.1016\/j.bbr.2022.114251","volume":"439","author":"NH Mat","year":"2023","unstructured":"Mat\u00a0NH, Bakar\u00a0SN, Murugaiyah\u00a0V et\u00a0al (2023) Analgesic effects of main indole alkaloid of kratom, mitragynine in acute pain animal model. Behav Brain Res 439:114251","journal-title":"Behav Brain Res"},{"issue":"2","key":"1721_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17512433.2024.2305798","volume":"17","author":"CR McCurdy","year":"2024","unstructured":"McCurdy\u00a0CR, Sharma\u00a0A, Smith\u00a0KE et\u00a0al (2024) An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations. Expert Rev Clin Pharmacol 17(2):131\u2013142","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1721_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000320288","volume":"16","author":"L McWhirter","year":"2010","unstructured":"McWhirter\u00a0L, Morris\u00a0S (2010) A Case Report of Inpatient Detoxification after Kratom (Mitragyna speciosa) Dependence. Eur Addict Res 16:229\u2013231","journal-title":"Eur Addict Res"},{"issue":"6","key":"1721_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1017\/S0140525X11000057","volume":"34","author":"CP M\u00fcller","year":"2011","unstructured":"M\u00fcller\u00a0CP, Schumann\u00a0G (2011) Drugs as instruments: a\u00a0new framework for non-addictive psychoactive drug use. Behav Brain Sci 34(6):293\u2013310","journal-title":"Behav Brain Sci"},{"key":"1721_CR38","doi-asserted-by":"publisher","first-page":"112672","DOI":"10.1016\/j.bbr.2020.112672","volume":"390","author":"CP M\u00fcller","year":"2020","unstructured":"M\u00fcller\u00a0CP (2020) Drug instrumentalization. Behav Brain Res 390:112672","journal-title":"Behav Brain Res"},{"key":"1721_CR39","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1038\/s41380-023-02074-3","volume":"28","author":"CP M\u00fcller","year":"2023","unstructured":"M\u00fcller\u00a0CP, Schumann\u00a0G, Rehm\u00a0J et\u00a0al (2023) Self-management with alcohol over lifespan: Psychological mechanisms, neurobiological underpinnings, and risk assessment. Mol Psychiatry 28:2683\u20132696","journal-title":"Mol Psychiatry"},{"issue":"7","key":"1721_CR40","doi-asserted-by":"publisher","first-page":"e04507","DOI":"10.1016\/j.heliyon.2020.e04507","volume":"6","author":"E M\u00fcller","year":"2020","unstructured":"M\u00fcller\u00a0E, Hillemacher\u00a0T, M\u00fcller\u00a0CP (2020) Kratom instrumentalization for severe pain self-treatment resulting in addiction\u2014A case report of acute and chronic subjective effects. Heliyon 6(7):e4507","journal-title":"Heliyon"},{"issue":"5","key":"1721_CR41","doi-asserted-by":"publisher","first-page":"e07039","DOI":"10.1016\/j.heliyon.2021.e07039","volume":"7","author":"E M\u00fcller","year":"2021","unstructured":"M\u00fcller\u00a0E, Hillemacher\u00a0T, M\u00fcller\u00a0CP (2021) Kratom use for depression\/anxiety self-management: challenges during the COVID-19 pandemic\u2014A case report. Heliyon 7(5):e7039","journal-title":"Heliyon"},{"key":"1721_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/07448481.2022.2112584","author":"MC Parent","year":"2022","unstructured":"Parent\u00a0MC, Woznicki\u00a0NW, Yang\u00a0J (2022) Demographic and behavioral factors associated with kratom use among U.S. college students. J\u00a0Am Coll Health. https:\/\/doi.org\/10.1080\/07448481.2022.2112584","journal-title":"J Am Coll Health"},{"issue":"12","key":"1721_CR43","first-page":"792","volume":"112","author":"WC Prozialeck","year":"2012","unstructured":"Prozialeck\u00a0WC, Jivan\u00a0JK, Andurkar\u00a0SV (2012) Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J\u00a0Am Osteopath Assoc 112(12):792\u2013799","journal-title":"J Am Osteopath Assoc"},{"issue":"3","key":"1721_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/jcpt.12676","volume":"43","author":"RB Raffa","year":"2018","unstructured":"Raffa\u00a0RB, Pergolizzi\u00a0JV, Taylor\u00a0R et\u00a0al (2018) Nature\u2019s first \u201catypical opioids\u201d: Kratom and mitragynines. J\u00a0Clin Pharm Therap 43(3):437\u2013441","journal-title":"J Clin Pharm Therap"},{"issue":"4","key":"1721_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.drugpo.2012.09.004","volume":"24","author":"D Saingam","year":"2013","unstructured":"Saingam\u00a0D, Assanangkornchai\u00a0S, Geater\u00a0AF, Balthip\u00a0Q (2013) Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: a\u00a0qualitative study. Int J Drug Policy 24(4):351\u2013358","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1721_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/02791072.2019.1686553","volume":"52","author":"A Saref","year":"2020","unstructured":"Saref\u00a0A, Suraya\u00a0S, Singh\u00a0D et\u00a0al (2020) Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (Mitragyna Speciosa korth.) Initiation among Illicit Drug Users in Malaysia. J\u00a0Psychoactive Drugs 52(2):138\u2013144","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"1721_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/add.15082","volume":"116","author":"J Schimmel","year":"2021","unstructured":"Schimmel\u00a0J, Amioka\u00a0E, Rockhill\u00a0K et\u00a0al (2021) Prevalence and description of Kratom (Mitragyna speciosa ) use in the United States: A\u00a0cross-sectional study. Addiction 116(1):176\u2013181","journal-title":"Addiction"},{"key":"1721_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/ADM.0b013e318221fbfa","volume":"5","author":"SV Sheleg","year":"2011","unstructured":"Sheleg\u00a0SV, Collins\u00a0GB (2011) A coincidence of addiction to \u201cKratom\u201d and severe primary hypothyroidism. J\u00a0Addict Med 5:300\u2013301","journal-title":"J Addict Med"},{"key":"1721_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugalcdep.2014.03.017","volume":"139","author":"D Singh","year":"2014","unstructured":"Singh\u00a0D, M\u00fcller\u00a0CP, Vicknasingam\u00a0BK (2014) Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend 139:132\u2013137","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1721_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/02791072.2015.1012610","volume":"47","author":"D Singh","year":"2015","unstructured":"Singh\u00a0D, M\u00fcller\u00a0CP, Vicknasingam\u00a0BK, Mansor\u00a0SM (2015) Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia. J\u00a0Psychoactive Drugs 47(2):125\u2013131","journal-title":"J Psychoactive Drugs"},{"key":"1721_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jep.2017.12.017","volume":"214","author":"D Singh","year":"2018","unstructured":"Singh\u00a0D, M\u00fcller\u00a0CP, Murugaiyah\u00a0V et\u00a0al (2018a) Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia. J\u00a0Ethnopharmacol 214:197\u2013206","journal-title":"J Ethnopharmacol"},{"issue":"Sup 1","key":"1721_CR52","first-page":"65","volume":"14","author":"D Singh","year":"2018","unstructured":"Singh\u00a0D, Chye\u00a0Y, Suo\u00a0C et\u00a0al (2018c) Brain magnetic resonance imaging of regular kratom (Mitragyna speciosa Korth.) users: a\u00a0preliminary study. Malay J Med Heal Sci 14(Sup 1):65\u201370","journal-title":"Malay J Med Heal Sci"},{"key":"1721_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jep.2018.12.038","volume":"233","author":"D Singh","year":"2019","unstructured":"Singh\u00a0D, Narayanan\u00a0S, M\u00fcller\u00a0CP et\u00a0al (2019a) Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia. J\u00a0Ethnopharmacol 233:34\u201340","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1721_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/02791072.2018.1555345","volume":"51","author":"D Singh","year":"2019","unstructured":"Singh\u00a0D, Narayanan\u00a0S, M\u00fcller\u00a0CP et\u00a0al (2019b) Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use. J\u00a0Psychoactive Drugs 51(1):19\u201327","journal-title":"J Psychoactive Drugs"},{"issue":"14","key":"1721_CR55","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1080\/10826084.2019.1645178","volume":"54","author":"D Singh","year":"2019","unstructured":"Singh\u00a0D, Narayanan\u00a0S, Grundmann\u00a0O et\u00a0al (2019c) Effects of Kratom (Mitragyna Speciosa Korth.) Use in Regular Users. Subst Use Misuse 54(14):2284\u20132289","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1721_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/2405461503666180420120649","volume":"8","author":"D Singh","year":"2019","unstructured":"Singh\u00a0D, Abdullah\u00a0MF, Vicknasingam\u00a0BK, M\u00fcller\u00a0CP (2019e) Substance use disorder related to kratom (Mitragyna speciosa) use in Malaysia. Curr Psychopharmacol 8(1):64\u201371","journal-title":"Curr Psychopharmacol"},{"key":"1721_CR57","doi-asserted-by":"publisher","first-page":"112462","DOI":"10.1016\/j.jep.2019.112462","volume":"249","author":"D Singh","year":"2020","unstructured":"Singh\u00a0D, Yeou Chear\u00a0NJ, Narayanan\u00a0S et\u00a0al (2020c) Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users. J\u00a0Ethnopharmacol 249:112462","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"1721_CR58","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1037\/pha0000518","volume":"30","author":"KE Smith","year":"2022","unstructured":"Smith\u00a0KE, Dunn\u00a0KE, Grundmann\u00a0O et\u00a0al (2022a) Social, psychological, and substance use characteristics of U.S. adults who use kratom: Initial findings from an online, crowdsourced study. Exp Clin Psychopharmacol 30(6):983\u2013996","journal-title":"Exp Clin Psychopharmacol"},{"issue":"6","key":"1721_CR59","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1080\/00952990.2022.2083967","volume":"48","author":"KE Smith","year":"2022","unstructured":"Smith\u00a0KE, Dunn\u00a0KE, Rogers\u00a0JM et\u00a0al (2022d) Kratom use as more than a\u00a0\u201cself-treatment\u201d. Am J Drug Alcohol Abuse 48(6):684\u2013694","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1721_CR60","doi-asserted-by":"publisher","first-page":"1174139","DOI":"10.3389\/fphar.2023.1174139","volume":"14","author":"KE Smith","year":"2023","unstructured":"Smith\u00a0KE, Feldman\u00a0JD, Dunn\u00a0KE et\u00a0al (2023) Examining the paradoxical effects of kratom: a\u00a0narrative inquiry. Front Pharmacol 14:1174139","journal-title":"Front Pharmacol"},{"key":"1721_CR61","doi-asserted-by":"crossref","unstructured":"Stanciu CN, Gnanasegaram SA, Rader GL III et\u00a0al (2023) What Is the Kratom Overdose Risk? A\u00a0Systematic Literature Review. Curr Addiction Rep: 1\u201320","DOI":"10.1007\/s40429-022-00464-1"},{"key":"1721_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainresbull.2016.03.015","volume":"126","author":"FW Suhaimi","year":"2016","unstructured":"Suhaimi\u00a0FW, Yusoff\u00a0NH, Hassan\u00a0R et\u00a0al (2016) Neurobiology of Kratom and its main alkaloid mitragynine. Brain Res Bull 126:29\u201340","journal-title":"Brain Res Bull"},{"issue":"13","key":"1721_CR63","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/bph.16352","volume":"181","author":"Y Suleiman","year":"2024","unstructured":"Suleiman\u00a0Y, M\u00fcller\u00a0CP, Hassan\u00a0Z (2024) Mitragynine (Kratom)-withdrawal behavior and cognitive impairments can be ameliorated by an epigenetic mechanism. Br J Pharmacol 181(13):2070\u20132084","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1721_CR64","first-page":"21","volume":"27","author":"S Suwanlert","year":"1975","unstructured":"Suwanlert\u00a0S (1975) A study of kratom eaters in Thailand. Bull Narc 27(3):21\u201327","journal-title":"Bull Narc"},{"issue":"5","key":"1721_CR65","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/02791072.2015.1096434","volume":"47","author":"MT Swogger","year":"2015","unstructured":"Swogger\u00a0MT, Hart\u00a0E, Erowid\u00a0F et\u00a0al (2015) Experiences of Kratom Users: A\u00a0Qualitative Analysis. J\u00a0Psychoactive Drugs 47(5):360\u2013367","journal-title":"J Psychoactive Drugs"},{"key":"1721_CR66","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.drugalcdep.2017.10.012","volume":"183","author":"MT Swogger","year":"2018","unstructured":"Swogger\u00a0MT, Walsh\u00a0Z (2018) Kratom use and mental health: A\u00a0systematic review. Drug Alcohol Depend 183:134\u2013140","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1721_CR67","doi-asserted-by":"publisher","first-page":"19158","DOI":"10.1038\/s41598-020-76119-w","volume":"10","author":"DA Todd","year":"2020","unstructured":"Todd\u00a0DA, Kellogg\u00a0JJ, Wallace\u00a0ED et\u00a0al (2020) Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions. Sci Rep 10(1):19158","journal-title":"Sci Rep"},{"issue":"4","key":"1721_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.drugpo.2009.12.003","volume":"21","author":"B Vicknasingam","year":"2010","unstructured":"Vicknasingam\u00a0B, Narayanan\u00a0S, Beng\u00a0GT, Mansor\u00a0SM (2010) The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy 21(4):283\u2013288","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1721_CR69","first-page":"229","volume":"93","author":"B Vicknasingam","year":"2020","unstructured":"Vicknasingam\u00a0B, Chooi\u00a0WT, Rahim\u00a0AA et\u00a0al (2020) Kratom and Pain Tolerance: A\u00a0Randomized, Placebo-Controlled, Double-Blind Study. Yale J Biol Med 93(2):229\u2013238","journal-title":"Yale J Biol Med"},{"issue":"1","key":"1721_CR70","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","volume":"130","author":"ML Warner","year":"2016","unstructured":"Warner\u00a0ML, Kaufman\u00a0NC, Grundmann\u00a0O (2016) The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. Int J Legal Med 130(1):127\u2013138","journal-title":"Int J Legal Med"},{"key":"1721_CR71","first-page":"53","volume":"2","author":"I Wray","year":"1907","unstructured":"Wray\u00a0I (1907a) \u201cBiak\u201d: An opium substitute. J\u00a0Fed Malay States Museum 2:53","journal-title":"J Fed Malay States Museum"},{"key":"1721_CR72","first-page":"1","volume":"18","author":"Y Yang","year":"2024","unstructured":"Yang\u00a0Y, M\u00fcller\u00a0CP, Singh\u00a0D (2024) Kratom (Mitragyna speciosa) Use and Mental Health: A\u00a0Systematic Review and Multilevel Meta-Analysis. Eur Addict Res 18:1\u201322","journal-title":"Eur Addict Res"},{"key":"1721_CR73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/adb.12185","volume":"21","author":"NH Yusoff","year":"2016","unstructured":"Yusoff\u00a0NH, Suhaimi\u00a0FW, Vadivelu\u00a0RK et\u00a0al (2016) Abuse potential and adverse cognitive effects of mitragynine (Kratom). Addict Biol 21:98\u2013110","journal-title":"Addict Biol"},{"key":"1721_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2017.05.059","volume":"332","author":"NH Yusoff","year":"2017","unstructured":"Yusoff\u00a0NH, Mansor\u00a0SM, M\u00fcller\u00a0CP, Hassan\u00a0Z (2017) Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats. Behav Brain Res 332:1\u20136","journal-title":"Behav Brain Res"},{"key":"1721_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.11.002","volume":"178","author":"NH Yusoff","year":"2022","unstructured":"Yusoff\u00a0NH, Hassan\u00a0Z, Murugaiyah\u00a0V, M\u00fcller\u00a0CP (2022) The effects of mitragynine (Kratom) on extracellular activity of brain dopamine and its metabolites. Brain Res Bull 178:1\u20138","journal-title":"Brain Res Bull"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01721-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01721-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01721-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T13:03:37Z","timestamp":1725455017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01721-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1721"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01721-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"22 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.P.\u00a0M\u00fcller, Y.\u00a0Yang, D.\u00a0Singh, B.\u00a0Lenz und E.\u00a0M\u00fcller geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}